Current and future directions in bacteriophage research for developing therapeutic innovations
Authors:
Open Access
- 17 October 2024
- journal article
- editorial
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-4
Abstract
Phages are gaining attention for their ability to target drug-resistant bacteria, disrupt biofilms, and reach intracellular pathogens, offering promising alternatives to traditional antibiotics. The Collection discusses advances in phage therapy, including their application in vaccine development, cancer immunotherapy, and gene delivery systems. Key research gaps are identified, such as challenges related to phage stability, immune response, and regulatory hurdles. Despite the progress, phage therapy faces obstacles in maintaining phage viability, evading immune detection, and navigating complex regulatory frameworks. The articles collectively address these challenges and propose potential solutions to enhance the effectiveness and acceptance of phage-based treatments. By overcoming these barriers, bacteriophage research has the potential to revolutionize medical therapies, providing innovative approaches to some of the most pressing healthcare challenges today.Keywords
This publication has 22 references indexed in Scilit:
- Bacteriophage DNA induces an interrupted immune response during phage therapy in a chicken modelNature Communications, 2024
- Investigation into scalable and efficient enterotoxigenic Escherichia coli bacteriophage productionScientific Reports, 2024
- Investigating bacteriophages as a novel multiple-hurdle measure against Campylobacter: field trials in commercial broiler plantsScientific Reports, 2024
- Optimized preparation pipeline for emergency phage therapy against Pseudomonas aeruginosa at Yale UniversityScientific Reports, 2024
- T7 phage-assisted evolution of riboswitches using error-prone replication and dual selectionScientific Reports, 2024
- The promise of phagesNature Biotechnology, 2023
- Antibacterial activity of vB_AbaM_PhT2 phage hydrophobic amino acid fusion endolysin, combined with colistin against Acinetobacter baumanniiScientific Reports, 2023
- Phage-based vaccinesAdvanced Drug Delivery Reviews, 2019
- A century of the phage: past, present and futureNature Reviews Microbiology, 2015
- Phage DisplayChemical Reviews, 1997